These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23354197)

  • 1. Cytomegalovirus disease in a renal transplant recipient: the importance of pre-transplant screening of the donor and recipient.
    Mitwalli AH; Nazmi A; Al Ghonaim M; Shaheen F; Kfoury H
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):80-5. PubMed ID: 23354197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus renal infection: Rare manifestation of a common post-transplant viral infection-A case series.
    Posadas Salas MA; Thompson J; Kadian M; Ngo T; Bruner E; Self S
    Transpl Infect Dis; 2019 Dec; 21(6):e13169. PubMed ID: 31498951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Batal I; Crew RJ
    Kidney Int; 2016 Aug; 90(2):455-456. PubMed ID: 27418098
    [No Abstract]   [Full Text] [Related]  

  • 4. Native kidney cytomegalovirus nephritis and cytomegalovirus prostatitis in a kidney transplant recipient.
    Tan SK; Cheng XS; Kao CS; Weber J; Pinsky BA; Gill HS; Busque S; Subramanian AK; Tan JC
    Transpl Infect Dis; 2019 Feb; 21(1):e12998. PubMed ID: 30203504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
    Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
    Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient.
    Rathi M; Gundlapalli S; Ramachandran R; Mohindra S; Kaur H; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    BMC Infect Dis; 2014 May; 14():259. PubMed ID: 24885965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.
    Balaha M; Al-Otaibi T; Gheith OA; Halim MA; Shaker M; Fayyad Z; Nair P; Zakaria Z; Abo-Atya H; Makkeyia Y
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):159-163. PubMed ID: 30777545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistant cytomegalovirus infection in related donor kidney allograft recipients].
    Goryainov VA; Kaabak MM; Babenko NN; Platova EN; Aganesov AG; Morozova MM; Panin VV
    Ter Arkh; 2016; 88(6):73-76. PubMed ID: 27296265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant Renal Arterial Vasculopathy of Donor Predicts Poor Renal Allograft Survival.
    Özdemir BH; Özdemir FN; Börcek P; Sercan Ç; Özdemir G; Ayvazoğlu Soy EH; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):41-46. PubMed ID: 29527990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
    Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
    Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
    Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
    BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections after kidney transplantation. Does age matter?
    Hemmersbach-Miller M; Alexander BD; Sudan DL; Pieper C; Schmader KE
    Clin Transplant; 2019 Apr; 33(4):e13516. PubMed ID: 30849194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2018; 50(1):124-129. PubMed ID: 29407294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
    Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
    Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M
    Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.
    Gill JS; Rose C; Joffres Y; Landsberg D; Gill J
    Am J Kidney Dis; 2018 May; 71(5):636-647. PubMed ID: 29395484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
    Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
    Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.